DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Max Healthcare Institute Limited (MAXHEALTH) share price today?

Max Healthcare Institute Limited (MAXHEALTH) is trading at ₹846 on the NSE, down 1.40% on the day. Source: DocStoX.

What is the PE ratio of Max Healthcare Institute Limited?

Max Healthcare Institute Limited has a price-to-earnings (PE) ratio of 57.0 in the Healthcare sector.

What is the market capitalisation of Max Healthcare Institute Limited?

Max Healthcare Institute Limited has a market capitalisation of approximately ₹82,245 crore.

Is Max Healthcare Institute Limited a profitable company?

Max Healthcare Institute Limited generates a return on equity of 13.4% with a net profit margin of 17.2%. That is a reasonable return on shareholder capital.

What is the 52-week high and low of MAXHEALTH?

Max Healthcare Institute Limited (MAXHEALTH) has traded between ₹842.05 and ₹1,221.9 over the past 52 weeks, against a current price of ₹846.

Does Max Healthcare Institute Limited pay a dividend?

Yes. Max Healthcare Institute Limited currently offers a dividend yield of 0.19%. Dividend payments depend on the board's declaration each year.

Max Healthcare Institute Limited

F&O

₹846.00▼ -12.00 (-1.40%)

MAXHEALTH·NSE·Healthcare

Market Cap

82244.72 Cr

PE Ratio

57.05

Volume

40,34,401

Day High - Low

865.40 - 842.30

52W High-Low

1221.90 - 842.05

₹846.00▼ -12.00 (-1.40%)

Market Cap82244.72 Cr

PE Ratio57.05

Volume40,34,401

Day High - Low865.40 - 842.30

52W High-Low1221.90 - 842.05

Max Healthcare Institute Limited (MAXHEALTH): company summary

The company's business has improved, with annual revenue rising 19.1% and annual net profit rising 34.1%.

Max Healthcare Institute Limited (MAXHEALTH) is a mid-cap Healthcare company valued at ₹82,245 crore operating in Hospital on the NSE and BSE.

Recent price move: Max Healthcare Institute Limited last traded at ₹846, modestly down 1.40% on the day.
Recent developments: On 2026-07-03, the company announced a dividend of ₹2.00 per share, with the ex-date set for that day. In the quarter ended 2026-06-30, net profit was ₹323 crore, up from ₹308 crore in the same quarter a year earlier. The company's promoter holding remained at 23.71% as of 2026-09-30.
Financial performance: The company's business has improved, with annual revenue rising 19.1% and annual net profit rising 34.1%. The latest quarter saw revenue increase 16.7% compared to the same quarter a year earlier, while net profit rose 4.9%.
Valuation multiples: The stock trades at 57.0 times earnings, a premium to the Healthcare median of 32.0, 9.41 times book value. It yields 0.2%.
Things to watch: The stock is 30.8% below its 52-week high. Foreign institutional holding decreased by 1.26 points in the quarter, while domestic institutional holding increased by 1.04 points. The net profit margin rose 1.9 percentage points to 17.2%.
Where it stands: The company's financials show growth, with annual revenue and net profit rising significantly. The latest quarter's net profit rose 4.9% compared to the same quarter a year earlier. The stock is 30.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.8/10

Weak

Fair Value

ROE

13.42%

Average

P/E

57.05x

Expensive

Debt / Equity

0.32

Moderate

Industry

Healthcare

Hospital

Overall View

Mixed

Price performance

NIFTY 50NIFTY 100NIFTY 200

Day₹842.30

₹865.40

52W₹842.05

₹1222

DocStoX take

Supported by risk (9.6) and quality (7.0), but held back by momentum (0.0). Risk looks strong at 9.6, but that is offset by valuation at 0.0 and momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

4.8

/10

Weak

Quality

Solid

ROE 13.4%

Valuation

Expensive

P/E 57.0×

Growth

Steady

Revenue +27.3% 5Y CAGR

Risk

Low risk

D/E 0.32

Momentum

Weak

1% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹846

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹82,245 Cr

52W High / Low

₹1222 / ₹842

Dividend Yield

0.19%

Promoter Holding

23.71%

EPS (TTM)

₹14.83

Book Value

₹110.43

Key highlights

Profitable in all of the last 5 years
Revenue compounding 27% a year
Healthy net margin (17%)
Valuation is weak (0.0/10)
Momentum is weak (0.0/10)

3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Hospital

Explore Max Healthcare Institute Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Max Healthcare Institute Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Max Healthcare Institute Limited with peers

Max Healthcare Institute Limited vs Sun Pharmaceutical Industries Limited Max Healthcare Institute Limited vs Divi's Laboratories Limited Max Healthcare Institute Limited vs Torrent Pharmaceuticals Limited Max Healthcare Institute Limited vs Apollo Hospitals Enterprise Limited Max Healthcare Institute Limited vs Zydus Lifesciences Limited Max Healthcare Institute Limited vs Laurus Labs Limited

Related tools & concepts

Value Max Healthcare Institute Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

MAXHEALTH newsLatest coverage & filings Open screenerFilter the whole market